Multiple Sclerosis Disease Activity and Disability Following Cessation of Fingolimod for Pregnancy.
Kerstin HellwigMarianne TokicSandra ThielSpalmai HematNina TimmesfeldAndrea I CipleaRalf GoldAnnette M Langer-GouldPublished in: Neurology(R) neuroimmunology & neuroinflammation (2023)
Relapses during pregnancy after fingolimod cessation are common. Approximately 6% of women will retain clinically meaningful disability from these pregnancy-related, fingolimod cessation relapses 1 year postpartum. This information should be shared with women on fingolimod desiring pregnancy, and optimizing MS treatment with nonteratogenic approaches should be discussed.
Keyphrases
- multiple sclerosis
- pregnancy outcomes
- disease activity
- preterm birth
- systemic lupus erythematosus
- rheumatoid arthritis
- white matter
- polycystic ovary syndrome
- pregnant women
- rheumatoid arthritis patients
- ankylosing spondylitis
- juvenile idiopathic arthritis
- healthcare
- mass spectrometry
- adipose tissue
- combination therapy
- insulin resistance
- health information
- smoking cessation